Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Asian Oncology Nursing
;
: 1-11, 2012.
Artigo
em Coreano
| WPRIM
| ID: wpr-24130
ABSTRACT
PURPOSE:
This study reviewed articles related to breast cancer, cognitive function and chemotherapy available in 4 databases.METHODS:
The researcher reviewed 32 pieces of literature that were published between January 2001 and November 2011.RESULTS:
Within the last decade, several studies have investigated whether adjuvant treatment of breast cancer affects cognitive function. A number of prospective studies have reported inconsistent results regarding whether chemotherapy affects cognitive function. Approximately half of the studies reported subtle cognitive decline in a wide range of domains among some breast cancer patients following chemotherapy, and others did not.CONCLUSION:
Breast cancer patients receiving adjuvant chemotherapy showed the most deterioration and the most persistent decline in cognitive function. Since cognitive impairment is subtle, if evident at all, discrepant findings are due to hormonal, physiological, psychological or temporal confounding variables and differences in study design. Especially, that chemotherapy may impair memory, executive function, attention and visuospatial function in women with breast cancer.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Mama
/
Neoplasias da Mama
/
Quimioterapia Adjuvante
/
Cognição
/
Função Executiva
/
Memória
Tipo de estudo:
Estudo observacional
Limite:
Feminino
/
Humanos
Idioma:
Coreano
Revista:
Asian Oncology Nursing
Ano de publicação:
2012
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS